Chapter 25, Cholinergic Drugs TEST BANK INTRODUCTORY CLINICAL PHARMACOLOGY 12TH EDITION By Susan M Ford
22 views 1 purchase
Course
INTRODUCTORY CLINICAL PHARMACOLOGY
Institution
INTRODUCTORY CLINICAL PHARMACOLOGY
TEST BANK INTRODUCTORY CLINICAL PHARMACOLOGY 12TH EDITION
By Susan M Ford
1. A client has been prescribed pyridostigmine for myasthenia gravis. The nurse
would be alert for the development of which adverse reaction following the
administration?
A) Seizure disorder
B) Reduction of visual acui...
TEST BANK INTRODUCTORY CLINICAL PHARMACOLOGY 12TH
EDITION By Susan M Ford
Chapter 25, Cholinergic Drugs
1. A client has been prescribed pyridostigmine for myasthenia gravis. The nurse
would be alert for the development of which adverse reaction following the
administration?
A) Seizure disorder
B) Reduction of visual acuity
C) Abdominal discomfort
D) Cardiac arrhythmias
Answer: D
Rationale: The nurse should monitor for cardiac arrhythmias as a general adverse
reaction in the client. Seizure disorder, reduction of visual acuity, and abdominal
discomfort are not pyridostigmine-related adverse reactions. Reduction of visual
acuity is related to topical ophthalmics. When the client is receiving bethanechol
for urinary retention, the nurse needs to examine for abdominal discomfort, which
is an adverse reaction of bethanechol and not pyridostigmine. Seizures are a
potential adverse reaction with lithium toxicity.
Question format: Multiple Choice
Chapter: 25
Learning Objective: 3
Cognitive Level: Apply
Client Needs: Physiological Integrity: Pharmacological Therapies
Integrated Process: Clinical Problem-solving Process (Nursing Process)
Reference: p. 313, Summary Drug Table
2. A client with urinary retention is prescribed bethanechol. The nurse will
administer this cautiously if which disorder is noted in the client's medical record?
A) Raynaud disease
B) Bradycardia
C) Coronary artery disease
D) Hyperthyroidism
Answer: B
Rationale: The nurse should administer bethanechol cautiously if a client has
bradycardia, hypertension, epilepsy, cardiac arrhythmias, recent coronary
occlusion, or megacolon. Individuals with coronary artery disease and
hyperthyroidism should not receive bethanechol as it is contraindicated.
Individuals with Raynaud disease should not receive alpha-adrenergic blocking
drugs.
Question format: Multiple Choice
Chapter: 25
Learning Objective: 2
Cognitive Level: Apply
, Client Needs: Physiological Integrity: Reduction of Risk Potential
Integrated Process: Clinical Problem-solving Process (Nursing Process)
Reference: p. 310, Precautions
3. A client was emergently administered bethanechol. Which finding on ongoing
assessment should the nurse prioritize and notify the health care provider
immediately?
A) Failure to void
B) Frequent emesis
C) Increased abdominal pain
D) Hematuria
Answer: A
Rationale: Bethanechol is used to treat acute nonobstructive urinary retention.
The nurse should notify the primary health care provider if the client fails to void
after drug administration. Nausea, emesis, and increased abdominal pain are
adverse effects of bethanechol. Hematuria is s potential adverse reaction to
sulfasalazine, a disease-modifying antirheumatic drug (DMARD).
Question format: Multiple Choice
Chapter: 25
Learning Objective: 3
Cognitive Level: Apply
Client Needs: Physiological Integrity: Reduction of Risk Potential
Integrated Process: Clinical Problem-solving Process (Nursing Process)
Reference: p. 311, Urinary Retention
4. The nurse is caring for a client with myasthenia gravis and has been administering
pyridostigmine. The nurse suspects the client needs an increased dose based on
which assessment finding?
A) Clenching of the jaw
B) Muscle spasms
C) Difficulty breathing
D) Abdominal cramping
Answer: C
Rationale: The nurse should monitor for difficulty breathing as a symptom of drug
underdosage. Additional signs of underdosing include signs of the disease, rapid
fatigability of muscles, and drooping of eyelids. Signs of overdosing include
muscle rigidity and spasms, salivation, and clenching of jaw. Abdominal cramping
may occur in the client who is receiving guanidine.
Question format: Multiple Choice
Chapter: 25
Learning Objective: 3
Cognitive Level: Analyze
Client Needs: Physiological Integrity: Pharmacological Therapies
Integrated Process: Clinical Problem-solving Process (Nursing Process)
Reference: p. 311, Managing Myasthenia Gravis
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller custojohnkeynes. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $3.41. You're not tied to anything after your purchase.
